This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Browse Topics

Cell & Gene Therapy

Fast track cell, gene & car-t commercialization from concept to robust patient-centric delivery.

Articles & Video

Showing 7 of 7 articles & video

Allogeneic and Autologous Cell Therapies Report 2022

The results of our study reveals emerging trends in the allogeneic and autologous cell therapy space.

Commercialization

Commercialization of Cell & Gene Therapies

This ebook presents insights from industry leaders, including partnering strategies, process technologies and control considerations.

Cell & gene therapy

COVID hit cell and gene therapy trials and suppliers but experts see signs of recovery

COVID-19 disrupted cell and gene therapy trials as well as the contractors and suppliers that support them, according to experts.

Autologous cell therapies: Commercialization strategies

This BioProcess International eBook looks at commercialization strategies for autologous cell therapies.

The current state and future of cell and gene therapies - Data report analysis

We analyse our recent cell and gene therapy survey data to explore the disease areas and products most being focused on currently and how respondents see the industry changing in the next two years.

How Kite Pharma are taking a CAR-T therapy to market

Kite Pharma VP of Product Services Marc Better discusses their work on developing a new cell therapy using CAR-T cells to treat lymphoma and leukemia patients. Watch the exclusive interview.

Cell and gene therapy

Cell therapy bioprocessing: Moving toward commercial scale and efficiency - WHITEPAPER

Our latest whitepaper explores the ways that progress towards commercial scale and efficiency in cell therapy bioprocessing is happening.

Cell and gene therapy

The commercialization of cell and gene therapies - WHITEPAPER

The commercialization of cell and gene therapies is already underway, but has an exciting future - this whitepaper explores both.